Chapter 2 34 Tertiles of NMR-measured Mg, mmol/L P trend 1 (< 0.73) 2 (0.73-0.77) 3 (> 0.77) CRP, mg/L 1.41 (0.64-3.14) 1.26 (0.58-2.77) 1.26 (0.60-2.86) 0.02 Creatinine, μmol/L 70.0 (61.0-79.0) 71.0 (62.0-80.0) 72.0 (64.0-81.0) <0.001 Cystatine C, mg/L 0.87 (0.78-0.98) 0.86 (0.78-0.96) 0.89 (0.80-0.99) <0.001 Estimated GFR , mL/min/1.732 93.6 ± 17.0 94.1 ± 16.2 90.3 ± 17.0 <0.001 Plasma levels of Albumin, g/L 43.3 ± 2.8 43.8 ± 2.6 44.2 ± 2.9 <0.001 Sodium, mmol/L 140.5 ± 2.0 140.7 ± 2.0 140.9 ± 2.1 <0.001 Potassium, mmol/L 4.20 ± 0.28 4.22 ± 0.26 4.25 ± 0.29 <0.001 Calcium, mmol/L 2.30 ± 0.12 2.30 ± 0.10 2.30 ± 0.11 0.06 Urinary excretions of Albumin, mg/24-h 9.0 (6.1-17.3) 8.2 (5.9-14.0) 8.3 (6.0-13.5) <0.001 Sodium, mmol/24-h 148.5 ± 56.3 144.3 ± 55.3 139.9 ± 53.5 <0.001 Urea, mmol/24-h 365.6 ± 112.8 367.8 ± 115.0 359.2 ± 110.8 0.07 Creatinine, mmol/24-h 12.7 ± 3.4 12.4 ± 3.3 12.2 ± 3.4 <0.001 Values are presented as means with SDs, medians with interquartile ranges, or percentages. Values are shown for non-imputed data. T2D, type 2 diabetes mellitus; GFR indicates glomerular filtration rate; HDL, high-density lipoprotein; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blockers; CRP, high sensitive C-reactive protein. Table 2. (Continued)
RkJQdWJsaXNoZXIy MTk4NDMw